These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17322488)

  • 21. Somatostatin receptor 2 expression determined by immunohistochemistry in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma, and Graves' disease.
    Sancak S; Hardt A; Singer J; Klöppel G; Eren FT; Güllüoglu BM; Sen LS; Sever Z; Akalin NS; Eszlinger M; Paschke R
    Thyroid; 2010 May; 20(5):505-11. PubMed ID: 20450431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSH-receptor expression and human thyroid disease: relation to clinical, endocrine, and molecular thyroid parameters.
    Schuppert F; Deiters S; Rambusch E; Sierralta W; Dralle H; von zur Muhlen A
    Thyroid; 1996 Dec; 6(6):575-87. PubMed ID: 9001192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function of HSP90 and p23 in the telomerase complex of thyroid tumors.
    Boltze C; Schneider-Stock R; Roessner A; Quednow C; Hoang-Vu C
    Pathol Res Pract; 2003; 199(9):573-9. PubMed ID: 14621192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules.
    Trovato M; Villari D; Bartolone L; Spinella S; Simone A; Violi MA; Trimarchi F; Batolo D; Benvenga S
    Thyroid; 1998 Feb; 8(2):125-31. PubMed ID: 9510120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma.
    Lo CY; Lam KY; Leung PP; Luk JM
    Eur J Endocrinol; 2005 Apr; 152(4):545-50. PubMed ID: 15817909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of pendrin in benign and malignant human thyroid tissues.
    Skubis-Zegadło J; Nikodemska A; Przytuła E; Mikula M; Bardadin K; Ostrowski J; Wenzel BE; Czarnocka B
    Br J Cancer; 2005 Jul; 93(1):144-51. PubMed ID: 15942636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of endothelin-1 in the normal and pathological human thyroid.
    Lenziardi M; Viacava P; Fiorini I; Castagna M; Nardini V; Pollina L; De Negri F; Goletti O; Di Coscio G; Bevilacqua G
    J Endocrinol Invest; 1995 May; 18(5):336-40. PubMed ID: 7594220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.
    Ruggeri RM; Villari D; Simone A; Scarfi R; Attard M; Orlandi F; Barresi G; Trimarchi F; Trovato M; Benvenga S
    J Endocrinol Invest; 2002 Dec; 25(11):959-66. PubMed ID: 12553555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific-differential display: decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors.
    Maeda I; Takano T; Matsuzuka F; Maruyama T; Higashiyama T; Liu G; Kuma K; Amino N
    Int J Cancer; 1999 May; 81(5):700-4. PubMed ID: 10328219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
    Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma.
    Tanaka T; Umeki K; Yamamoto I; Sakamoto F; Noguchi S; Ohtaki S
    Int J Cancer; 1995 Oct; 64(5):326-31. PubMed ID: 7591305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like.
    Giannini R; Moretti S; Ugolini C; Macerola E; Menicali E; Nucci N; Morelli S; Colella R; Mandarano M; Sidoni A; Panfili M; Basolo F; Puxeddu E
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3557-3575. PubMed ID: 30882858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-time analysis of beta- and gamma-catenin mRNA expression in ret/PTC-1 activated and nonactivated thyroid tissues.
    Smyth P; Finn S; O'Leary J; Sheils O
    Diagn Mol Pathol; 2003 Mar; 12(1):44-9. PubMed ID: 12605035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
    Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
    Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
    Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
    Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase 1 and 2 expressions in the human thyroid gland.
    Lee HM; Baek SK; Kwon SY; Jung KY; Chae SW; Hwang SJ; Woo JS; Lee JY
    Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):199-204. PubMed ID: 16362262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical demonstration of thyroid peroxidase (TPO) in human thyroid tissues from various thyroid diseases.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Arai Y; Kotani T; Ohtaki S; Matsukawa S
    Anticancer Res; 1994; 14(3B):1329-34. PubMed ID: 8067701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the ring ligase PRAJA2 in thyroid cancer.
    Cantara S; D'Angeli F; Toti P; Lignitto L; Castagna MG; Capuano S; Prabhakar BS; Feliciello A; Pacini F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4253-9. PubMed ID: 22948757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.